- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
AstraZeneca
Market Cap: UK£165.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£107.00
7D
2.9%
1Y
-15.0%
Diaceutics
Market Cap: UK£112.4m
A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.33
7D
-3.3%
1Y
1.9%